​

RxSight (RXST) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

RXST Stock Forecast

RxSight (RXST) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $70.14, with a high of $110.00 and a low of $52.00. This represents a 104.73% increase from the last price of $34.26.

$30 $46 $62 $78 $94 $110 High: $110 Avg: $70.14 Low: $52 Last Closed Price: $34.26

RXST Stock Rating

RxSight stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 8 Strong Sell Sell Hold Buy Strong Buy

RXST Price Target Upside V Benchmarks

TypeNameUpside
StockRxSight104.73%
SectorHealthcare Stocks 25.00%
IndustryMedical Device Stocks6.94%

Price Target Trends

1M3M12M
# Anlaysts--14
Avg Price Target--$69.64
Last Closing Price$34.26$34.26$34.26
Upside/Downside--103.27%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25352--10
Jan, 25352--10
Dec, 24372--12
Nov, 2446---10
Oct, 2446---10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 29, 2024Curry BakerGuggenheim$52.00$52.00-51.78%
Oct 29, 2024Anthony CrowdellMizuho Securities$67.00$52.0028.85%95.56%
Oct 29, 2024Adam SeidenBarclays$110.00$52.00111.54%221.07%
Oct 29, 2024Young LiJefferies$72.00$50.2543.28%110.16%
Sep 23, 2024Ryan ZimmermanBTIG$59.00$52.9811.36%72.21%
Sep 13, 2024David SaxonNeedham$66.00$54.5421.01%92.64%
Aug 06, 2024Thomas StephanStifel Nicolaus$65.00$40.7859.39%89.73%
Aug 06, 2024David SaxonNeedham$54.00$47.1514.53%57.62%
May 07, 2024Steven LichtmanOppenheimer$72.00$62.8414.58%110.16%
May 07, 2024David SaxonNeedham$75.00$62.8419.35%118.91%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 29, 2024BarclaysOverweightinitialise
Oct 29, 2024Wells FargoBuyBuyhold
Oct 29, 2024JefferiesBuyinitialise
Sep 23, 2024BTIGBuyBuyhold
Sep 13, 2024Wells FargoBuyBuyhold
Sep 13, 2024NeedhamBuyBuyhold
Aug 06, 2024NeedhamBuyBuyhold
May 07, 2024Stifel NicolausBuyBuyhold
May 07, 2024OppenheimerOutperformOutperformhold
May 07, 2024NeedhamBuyBuyhold

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.57$-2.41$-1.41-----
Avg Forecast$-2.66$-2.61$-1.53$-0.72$-0.45$-0.05$-0.08$-0.14
High Forecast$-2.79$-2.78$-1.56$-5.06$-0.90$-0.12$-0.08$-0.14
Low Forecast$-2.51$-2.50$-1.48$5.06$-0.13$0.03$-0.07$-0.14
Surprise %34.21%-7.66%-7.84%-----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$22.59M$49.01M$89.08M-----
Avg Forecast$22.04M$48.76M$88.44M$140.03M$188.50M$231.79M$284.80M$300.70M
High Forecast$21.04M$47.21M$86.59M$139.97M$187.66M$231.11M$273.70M$294.39M
Low Forecast$22.84M$51.18M$89.27M$140.10M$189.45M$232.46M$295.90M$303.50M
Surprise %2.53%0.50%0.72%-----

Net Income Forecast

$-200M $-120M $-40M $40M $120M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-48.69M$-66.76M$-48.61M-----
Avg Forecast$-91.76M$-89.86M$-52.40M$-30.69M$-17.24M$-1.03M$-2.56M$-4.82M
High Forecast$-96.13M$-95.64M$-53.78M$-174.36M$-30.96M$-4.14M$-2.62M$-4.88M
Low Forecast$-86.38M$-86.15M$-51.02M$174.36M$-4.59M$973.35K$-2.51M$-4.69M
Surprise %-46.94%-25.71%-7.24%-----

RXST Forecast FAQ

Is RxSight stock a buy?

RxSight stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that RxSight is a favorable investment for most analysts.

What is RxSight's price target?

RxSight's price target, set by 8 Wall Street analysts, averages $70.14 over the next 12 months. The price target range spans from $52 at the low end to $110 at the high end, suggesting a potential 104.73% change from the previous closing price of $34.26.

How does RxSight stock forecast compare to its benchmarks?

RxSight's stock forecast shows a 104.73% upside, outperforming the average forecast for the healthcare stocks sector (25.00%) and outperforming the medical device stocks industry (6.94%).

What is the breakdown of analyst ratings for RxSight over the past three months?

  • February 2025: 30.00% Strong Buy, 50.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 30.00% Strong Buy, 50.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 25.00% Strong Buy, 58.33% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.

What is RxSight’s EPS forecast?

RxSight's average annual EPS forecast for its fiscal year ending in December is $-0.72 for 2024, a -48.94% decrease from the reported $-1.41 in 2023. The prediction for 2025 is $-0.45, $-0.05 for 2026, $-0.08 for 2027, and $-0.14 for 2028.

What is RxSight’s revenue forecast?

RxSight's average annual revenue forecast for its fiscal year ending in December is $140.03M for 2024, a 57.20% increase from the reported $89.08M in 2023. The forecast for 2025 is $188.5M, $231.79M for 2026, $284.8M for 2027, and $300.7M for 2028.

What is RxSight’s net income forecast?

For its fiscal year ending in December, RxSight's average annual net income forecast is $-30.694M for 2024, reflecting a -36.85% decrease from the reported $-48.608M in 2023. The projection for 2025 is $-17.241M, $-1.029M for 2026, $-2.564M for 2027, and $-4.824M for 2028.